Finance

Lists
Why is NSRX down 4,82%?
Dive Deeper
NSRX:NYSEAMERICAN
Nasus Pharma Ltd
3,16 $
-4,82%
(-0,16) 1D
13 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NSRX...
Open
3,22 $
High
3,33 $
Low
3,10 $
Mkt. cap
37,02 млн
Avg. vol.
18,70 мың
Volume
13,42 мың
52-wk high
9,50 $
52-wk low
1,98 $
EPS
-1,13 $
Shares outstanding
11,71 млн
No. of employees
7
Open
3,22 $
High
3,33 $
Low
3,10 $
Mkt. cap
37,02 млн
Avg. vol.
18,70 мың
Volume
13,42 мың
52-wk high
9,50 $
52-wk low
1,98 $
EPS
-1,13 $
Shares outstanding
11,71 млн
No. of employees
7
News stories
From web sources and news partners
About Nasus Pharma Ltd
CEO-
Employees7
Founded2019
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
1,29 млн
1,29 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
1,73 млн
1,73 млн
Operating expense
-
-
3,02 млн
3,02 млн
Total operating expenses
-
-
3,02 млн
3,02 млн
Operating income
-
-
-3,02 млн
-3,02 млн
Other non operating income
-
-
-17,50 мың
-17,50 мың
EBT including unusual items
-
-
-2,97 млн
-2,97 млн
EBT excluding unusual items
-
-
-2,97 млн
-2,97 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-2,97 млн
-2,97 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
64,00 мың
64,00 мың
Interest expense
-
-
-
-
Net interest expenses
-
-
64,00 мың
64,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары